Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
European Journal of Pharmacology
|
March 28, 2008
MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse
Fabrizio Gardoni
Frontiers in Cellular Neuroscience
|
March 19, 2015
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
Fabrizio Gardoni, Camilla Bellone
European Journal of Pharmacology
|
July 23, 2013
Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system
Manuela Mellone, Fabrizio Gardoni
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 2, 2018
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications
Manuela Mellone, Fabrizio Gardoni
Current Opinion in Pharmacology
|
December 3, 2014
Targeting glutamatergic synapses in Parkinson's disease
Fabrizio Gardoni, Monica Di Luca
Neuropharmacology
|
April 5, 2021
Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers
Fabrizio Gardoni, Monica Di Luca
European Journal of Pharmacology
|
July 13, 2006
New targets for pharmacological intervention in the glutamatergic synapse
Fabrizio Gardoni, Monica Di Luca
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 22, 2025
An update on drug repurposing in Parkinson's disease: Preclinical and clinical considerations
Michela Salvadè, Monica DiLuca, Fabrizio Gardoni
International Review of Neurobiology
|
August 7, 2007
Cytokines and neuronal ion channels in health and disease
Barbara Viviani, Fabrizio Gardoni, Marina Marinovich
Journal of Neurochemistry
|
July 25, 2015
Alzheimer's disease and modern lifestyle: what is the role of stress?
Elena Marcello, Fabrizio Gardoni, Monica Di Luca
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
European Journal of Pharmacology
|
March 28, 2008
MAGUK proteins: new targets for pharmacological intervention in the glutamatergic synapse
Fabrizio Gardoni
Frontiers in Cellular Neuroscience
|
March 19, 2015
Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases
Fabrizio Gardoni, Camilla Bellone
European Journal of Pharmacology
|
July 23, 2013
Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system
Manuela Mellone, Fabrizio Gardoni
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 2, 2018
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications
Manuela Mellone, Fabrizio Gardoni
Current Opinion in Pharmacology
|
December 3, 2014
Targeting glutamatergic synapses in Parkinson's disease
Fabrizio Gardoni, Monica Di Luca
Neuropharmacology
|
April 5, 2021
Protein-protein interactions at the NMDA receptor complex: From synaptic retention to synaptonuclear protein messengers
Fabrizio Gardoni, Monica Di Luca
European Journal of Pharmacology
|
July 13, 2006
New targets for pharmacological intervention in the glutamatergic synapse
Fabrizio Gardoni, Monica Di Luca
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 22, 2025
An update on drug repurposing in Parkinson's disease: Preclinical and clinical considerations
Michela Salvadè, Monica DiLuca, Fabrizio Gardoni
International Review of Neurobiology
|
August 7, 2007
Cytokines and neuronal ion channels in health and disease
Barbara Viviani, Fabrizio Gardoni, Marina Marinovich
Journal of Neurochemistry
|
July 25, 2015
Alzheimer's disease and modern lifestyle: what is the role of stress?
Elena Marcello, Fabrizio Gardoni, Monica Di Luca
Page
of 14